Synergistic drug combination effectively blocks Ebola virus infection-Reference-Cited by-同舟云学术

Synergistic drug combination effectively blocks Ebola virus infection

Published:2017-01 Issue: Volume:137 Page:165-172
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Sun Wei,He Shihua,Martínez-Romero Carles,Kouznetsova Jennifer,Tawa Gregory,Xu Miao,Shinn Paul,Fisher Ethan G.,Long Yan,Motabar Omid,Yang Shu,Sanderson Philip E.,Williamson Peter R.,García-Sastre Adolfo,Qiu Xiangguo,Zheng Wei^ORCID

Funder

NIH

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference32 articles.

1. A 4-Drug combination (viekira pak) for hepatitis C;Abramowicz;Jama-J Am. Med. Assoc.,2015

2. Sensitive determination of clarithromycin in human plasma by high-performance liquid chromatography with spectrophotometric detection;Amini;J. Chromatogr. B Anal. Technol. Biomed. Life Sci.,2005

3. Antibiotic resistance and its cost: is it possible to reverse resistance?;Andersson;Nat. Rev. Microbiol.,2010

4. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1;Carette;Nature,2011

5. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection;Chandran;Science,2005

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drupacine as a potent SARS-CoV-2 replication inhibitor in vitro;Biosafety and Health;2024-09

2. Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections;Asian Pacific Journal of Tropical Medicine;2024-07

3. Two-way pharmacodynamic modeling of drug combinations and its application to pairs of repurposed Ebola and SARS-CoV-2 agents;Antimicrobial Agents and Chemotherapy;2024-04-03

4. Tubeimosides are pan-coronavirus and filovirus inhibitors that can block their fusion protein binding to Niemann-Pick C1;Nature Communications;2024-01-02

5. Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches;Infectious Diseases and Therapy;2024-01